Plain-English translation of NCT07122531 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing medium-chain triglyceride oil (MCT oil)—a supplement that may help your brain use energy more efficiently—as an add-on to your current antipsychotic medication. The study involves taking MCT oil twice daily for 12 weeks while continuing your regular psychiatric treatment. Researchers want to see if this supplement can improve how your brain uses glucose and ketones for energy, and whether it helps reduce psychosis symptoms.
Many people with psychosis have underlying problems with how their brain uses energy for fuel—something that happens even before starting antipsychotic medications. While antipsychotics are the main treatment, they don't work completely for everyone, and they can sometimes cause metabolic side effects like weight gain and blood sugar problems. This medication offers a potential way to support brain energy metabolism without major diet changes, something that might help both symptoms and overall health.
You likely qualify if…
You likely don't qualify if…
You would continue taking your regular antipsychotic medication and add MCT oil to your daily routine—15 grams mixed into a drink of your choice, twice a day (morning and evening), for 12 weeks. The study will monitor your blood work to measure ketone levels, blood sugar, and insulin, along with checking how you're feeling and whether the supplement is easy to use. You'll need to attend clinic visits for check-ins and blood tests during the 12-week period.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Canada